Antihyperlipidemic Effect of Curcumin and Tetrahydrocurcumin in Experimental Type 2 Diabetic Rats

REFERENCES

• Howard BV, Savage PJ, Bennion LJ, Bennett PH. Lipoprotein composition in diabetes mellitus. Atheroscler. 1978; 30: 153–162
   PubMed Web of Science ®Google Scholar
• Nikkila EA, Kekki M. Plasma triglyceride transport in diabetes mellitus. Metabolism. 1973; 22: 1–22
   PubMedGoogle Scholar
• Satyanarayana K. Chemical examination of Scoparia dulcis (Linn): Part I. J. Indian Chem. Soc. 1969; 46: 765–766
   Web of Science ®Google Scholar
• Sochor M, Baquer NZ, McLean P. Glucose over and under utilization in diabetes: Comparative studies on the changes in the activities of enzymes of glucose metabolism in rat kidney and liver. Mol. Physiol. 1985; 7: 51–68
   Google Scholar
• Gupta BL, Baquer NZ. Hexokinase, glucose-6-phosphate dehydrogenase and antioxidant enzymes in diabetic reticulocytes: Effects of insulin and vanadate. Biochem. Mol. Biol. Int. 1998; 46: 1145–1152
   PubMedGoogle Scholar
• Aggarwal B, Kumar A, Bharti A. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res. 2003; 23: 363–398
   PubMed Web of Science ®Google Scholar
• Babu P, Srinivasan K. Hypolipidemic action of curcumin, the active principle of turmeric Curcuma longa in streptozotocin induced diabetic rats. Mol. Cell. Biochem. 1997; 166: 169–175
   PubMed Web of Science ®Google Scholar
• Suryanarayana P, Saraswat M, Mrudula T, Krishna P, Krishnaswamy K, Reddy G. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest. Ophthalmol. Vis. Sci. 2005; 46: 2092–2099
   PubMed Web of Science ®Google Scholar
• Babu P, Srinivasan K. Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats. Mol. Cell. Biochem. 1998; 181: 87–96
   PubMed Web of Science ®Google Scholar
• Sajithlal G, Chithra P, Chandrakasan G. Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem. Pharmacol. 1998; 56: 1607–1614
   PubMed Web of Science ®Google Scholar
• Nishiyama T, Mae T, Kishida H, Tsukagawa M, Mimaki Y, Kuroda M. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L) suppress and increase in blood glucose level in type 2 diabetic KK-Ay mice. J. Agric. Food. Chem. 2005; 53: 959–963
   PubMed Web of Science ®Google Scholar
• Mahesh T, Balasubashini M, Menon V. Effect of photo-irradiated curcumin treatment against oxidative stress in streptozotocin-induced diabetic rats. J. Med. Food. 2005; 8: 251–255
   PubMed Web of Science ®Google Scholar
• Sidhu G, Mani H, Gaddipati J, Singh A, Seth P, Banaudha K. Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound. Rep. Regen. 1999; 7: 362–374
   PubMed Web of Science ®Google Scholar
• Holder GM, Plummer JL, Ryan AJ. The metabolism and excretion of curcumin (1,7,-bis(4-hydroxy-3-methoxyphenyl)-1,6-hepadiene-3,5-dione) in rat. Xenobiotica. 1978; 8: 761–768
   PubMed Web of Science ®Google Scholar
• Naito M, Wu X, Normura H, Kodama M, Kato Y, Osaswa T. The protective effect of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits. J. Atheroscler. Thromb. 2002; 9: 243–250
   PubMedGoogle Scholar
• Okada K, Wangpoengtrakul C, Tanaka T, Toyokuni S, Uchida K, Osawa T. Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. J. Nutr. 2001; 31: 2090–2095
   Google Scholar
• Pari L, Murugan P. Protective role of tetrahydrocurcumin against erythromycin estolate induced hepatotoxicity. Pharmacol. Res. 2004; 49: 481–486
   PubMed Web of Science ®Google Scholar
• Sugiyama Y, Kawakishi S, Osawa T. Involvement of the β-diketone moiety in the antioxidant mechanism of tetrahydrocurcuminoids. Biochem. Pharmacol. 1996; 52: 519–525
   PubMed Web of Science ®Google Scholar
• Lin JK, Lin–Shiau SY. Mechanisms of cancer chemoprevention by curcumin. Pro. Natl. Sci. Counc. Repub. China. 2001; 25: 59–66
   PubMedGoogle Scholar
• Pari L, Murugan P. Effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats. J. Basic Clin. Physiol. Pharmacol. 2005; 16: 257–274
   PubMedGoogle Scholar
• Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D. Experimental NIDDM: Development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes. 1998; 47: 224–229
   PubMed Web of Science ®Google Scholar
• Murugan P, Pari L. Antioxidant effect of tetrahydrocurcumin in streptozotocin—nicotinamide induced diabetic rats. Life Sci. 2006; 79: 1720–1728
   PubMed Web of Science ®Google Scholar
• Folch J, Lees M, Solane SGH. A simple method for isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957; 226: 497–509
   PubMed Web of Science ®Google Scholar
• Lott JA, Turner K. Evaluation of trinder's glucose oxidase method for measuring glucose in serum and urine. Clin. Chem. 1975; 21/12: 1754–1760
   Google Scholar
• Zlatkis A, Zak B, Boyle GJ. A method for the determination of serum cholesterol. J. Clin. Med. 1953; 41: 486–492
   PubMed Web of Science ®Google Scholar
• Burnstein M, Scholnic MR, Mortin R. Rapid method of isolation of lipoprotein from human serum by precipitation of polyanion. J. Lipid Res. 1970; 11: 583–587
   PubMed Web of Science ®Google Scholar
• Friedwerd WT, Levy RI, Fredrickson DS. Estimation of concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin. Chem. 1972; 18: 499–502
   PubMedGoogle Scholar
• Foster JB, Dunn RT. Stable reagents for determination of serum triglyceride by colorimetric condensation method. Clin. Chim. Acta. 1973; 19: 338–340
   Google Scholar
• Falholt K, Falholt W, Lund B. An assay colorimetric method for routine determination of free fatty acids in plasma. Clin. Chim. Acta. 1973; 46: 105–111
   PubMed Web of Science ®Google Scholar
• Zilversmit BB, Davis AK. Micro determination of plasma phospholipids by TCA precipitation. J. Lab. Clin. Med. 1950; 35: 155–160
   PubMed Web of Science ®Google Scholar
• Philipp B, Shapiro DJ. Improved methods for the assay and activation of 3-hydroxy-3-methylglutaryl-co-enzyme A reductase. J. Food Res. 1979; 20: 588–593
   Google Scholar
• Duncan BD. Multiple range test for correlated and heteroscedastic means. Biometrics. 1957; 13: 359–364
   Web of Science ®Google Scholar
• Scheen AJ. Pathophysiology of type 2 diabetes. Acta. Clin. Belg. 2003; 58: 335–341
   PubMed Web of Science ®Google Scholar
• Maassen JA, Van den Ouweland JM, Losekoot M, Lemkes HH. From gene to disease: Mutation in mitochondrial DNA and maternally inherited diabetes mellitus with deafness (MIDD). Ned. Tijdschr. Geneeskd. 2001; 145: 1153–1154
   PubMedGoogle Scholar
• Shih DQ, Stoffel M. Molecular etiologies of MODY and other early onset forms of diabetes. Curr. Diab. Rep. 2002; 2: 125–134
   PubMedGoogle Scholar
• Froguel P, Velho G. Genetic determinants of type 2 diabetes. Recent Prog. Horm. Res. 2001; 56: 91–105
   PubMedGoogle Scholar
• Brown GB, Xue-Qiao Z, Sacco DE, Alberts JJ. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation. 1993; 87: 1781–1791
   PubMed Web of Science ®Google Scholar
• Rhoads GG, Gulbrandse CL, Kagan A. Serum lipoproteins and coronary artery disease in a population study of Hawaiian Japanese men. New. Engl. J. Med. 1976; 294: 293–298
   PubMed Web of Science ®Google Scholar
• Yanni AE, Yatzidis HA, Kavantzas NG, Agapitos EV, Perrea DN, Karayannacos PE. Dietary L-aspartate and L-glutamate inhibit fatty streak initiation in cholesterol-fed rabbit. Nutr. Metab. Cardiovasc. Dis. 2003; 13: 80–86
   PubMedGoogle Scholar
• Segal P, Bachorik PS, Rifkind BM, Levy RI. Lipids and dyslipoproteinemia. Clinical Diagnosis and Management by Laboratory Methods17th, JH Bernard, DA Nelson, RH Tomar, JA Washington, WB Saunders. W.B. Saunders, Philadelphia 1984; 180–203
   Google Scholar
• Bopanna KN, Kannan J, Sushma G, Balaraman R, Rathod SP. Antidiabetic and antihyperlipidemic effects of Neem seed kernel powder on alloxan diabetic rabbits. Indian J. Pharmacol. 1997; 29: 162–167
   Google Scholar
• Pushparaj P, Tan CH, Tan BK. Effects of Averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin-diabetic rats. J. Ethnopharmacol. 2000; 72: 69–76
   PubMed Web of Science ®Google Scholar
• Lehto S, Haffner SM, Pyorala K, Kallio V, Laakso M. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes. 1997; 46: 1354–1359
   PubMed Web of Science ®Google Scholar
• Taskinen MR, Lahdenpera S, Syvanne M. New insights into lipid metabolism in non-insulin-dependent diabetes mellitus. Ann. Med. 1996; 28: 335–340
   PubMed Web of Science ®Google Scholar
• Eisenberg S. Preferential enrichment of large sized very low-density lipoprotein populations with transferred cholesterylesters. J. Lipid Res. 1985; 26: 487–494
   PubMedGoogle Scholar
• Frayn KN. Insulin resistance and lipid metabolism. Curr. Opin. Lipidol. 1993; 4: 197–204
   Google Scholar
• Ashokumar N, Pari L, Manimakalai A, Selvarau. Effect of N-benzoyl-D-phenylalanine on streptozotocin induced changes in the lipid and lipoprotein profile in rats. J. Pharm. Pharmacol. 2005; 57: 359–366
   PubMedGoogle Scholar
• Blum J, Fridovich I. Inactivation of glutathione peroxidase by superoxide radical. Arch. Biochem. Biophys. 1985; 240: 500–508
   PubMed Web of Science ®Google Scholar